Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Neumora Therapeutics, Inc. Common Stock
Market Cap
$87.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$87.85M
Net Profit Margin
-269.42%
TTM Avg
-19.58%
3Y Avg
-904.79%
5Y Avg
-881.91%
Market Cap
$87.96M
Net Profit Margin
6.21%
TTM Avg
8.02%
3Y Avg
-5.41%
5Y Avg
-4.66%
Market Cap
$85.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.44M
Net Profit Margin
-39.96%
TTM Avg
-45.40%
3Y Avg
-116.56%
5Y Avg
-242.44%
Market Cap
$89.78M
Net Profit Margin
0.00%
TTM Avg
-9.81%
3Y Avg
-113.18%
5Y Avg
-75.45%
Market Cap
$90.20M
Net Profit Margin
2.57%
TTM Avg
-5.95%
3Y Avg
-14.59%
5Y Avg
-10.91%
Market Cap
$90.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. Common Stock (NMRA) | $87.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | -269.42% | -19.58% | -904.79% | -881.91% |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 6.21% | 8.02% | -5.41% | -4.66% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| electroCore, Inc. (ECOR)vs › | $89.44M | -39.96% | -45.40% | -116.56% | -242.44% |
| Equillium, Inc. (EQ)vs › | $89.78M | 0.00% | -9.81% | -113.18% | -75.45% |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 2.57% | -5.95% | -14.59% | -10.91% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rallybio Corporation (RLYB)vs › | $90.64M | 7051.24% | -5065.26% | -2532.63% | -1688.42% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
